AQR Capital Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-3,300
| Closed | -$322K | – | 2319 |
|
|
2015
Q1 | $322K | Sell |
3,300
-16,300
| -83% | -$1.59M | ﹤0.01% | 1846 |
|
|
2014
Q4 | $1.82M | Buy |
19,600
+4,800
| +32% | +$445K | ﹤0.01% | 1340 |
|
|
2014
Q3 | $1.02M | Buy |
14,800
+7,400
| +100% | +$509K | ﹤0.01% | 1615 |
|
|
2014
Q2 | $776K | Buy |
7,400
+1,800
| +32% | +$189K | ﹤0.01% | 1771 |
|
|
2014
Q1 | $465K | Buy |
+5,600
| New | +$465K | ﹤0.01% | 2077 |
|
|
2013
Q4 | – | Sell |
-51,800
| Closed | -$3.28M | – | 2665 |
|
|
2013
Q3 | $3.28M | Buy |
51,800
+40,800
| +371% | +$2.58M | 0.01% | 1003 |
|
|
2013
Q2 | $462K | Buy |
+11,000
| New | +$462K | ﹤0.01% | 1927 |
|